StockData
Viatris Inc logo

Viatris Inc (VTRS) stock

VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/303% below fair value
$19.88−0.40 (-1.97%)

Close on Nov 19, 2026Market cap $22.83BP/E –Yield 2.41%

Viatris shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Viatris's shares outstanding was 1.16B at Jun 30, 2026. For fiscal 2023 it was 1.21B, down 0.9% from the year before. The highest annual figure on record is 1.22B in fiscal 2022.

Annual shares outstanding

PeriodPeriod endValueChange
FY2023Dec 31, 20231.21B-0.9%
FY2022Dec 31, 20221.22B+0.7%
FY2021Dec 31, 20211.21B+101.1%
FY2020Dec 31, 2020601M+16.4%
FY2019Dec 31, 2019517M0.0%
FY2018Dec 31, 2018517M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20261.16B-2.4%
Q1 FY2026Mar 31, 20261.18B-2.1%
Q3 FY2025Sep 30, 20251.16B-2.2%
Q2 FY2025Jun 30, 20251.17B-3.0%
Q1 FY2025Mar 31, 20251.19B-1.5%
Q3 FY2024Sep 30, 20241.20B-0.6%
Q2 FY2024Jun 30, 20241.19B-1.0%
Q1 FY2024Mar 31, 20241.21B+0.3%
Q4 FY2023Dec 31, 20231.21B-0.9%
Q3 FY2023Sep 30, 20231.21B-0.9%
Q2 FY2023Jun 30, 20231.20B-1.1%
Q1 FY2023Mar 31, 20231.21B-0.6%
Q4 FY2022Dec 31, 20221.22B+1.0%
Q3 FY2022Sep 30, 20221.22B+0.5%
Q2 FY2022Jun 30, 20221.22B+0.7%
Q1 FY2022Mar 31, 20221.21B+0.5%
Q4 FY2021Dec 31, 20211.21B+41.8%
Q3 FY2021Sep 30, 20211.21B+134.2%
Q2 FY2021Jun 30, 20211.21B+133.7%
Q1 FY2021Mar 31, 20211.21B+133.6%
Q4 FY2020Dec 31, 2020853M+852899900.0%
Q3 FY2020Sep 30, 2020518M+517699900.0%
Q2 FY2020Jun 30, 2020517M–
Q1 FY2020Mar 31, 2020517M–
Q3 FY2019Sep 29, 20190M–
Q2 FY2019Jun 30, 20190M–

More Viatris figures

See a number that looks wrong?